These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

549 related articles for article (PubMed ID: 11074395)

  • 21. Amantadine and the place of acupuncture in the treatment of fatigue in patients with multiple sclerosis: an observational study.
    Foroughipour M; Bahrami Taghanaki HR; Saeidi M; Khazaei M; Sasannezhad P; Shoeibi A
    Acupunct Med; 2013 Mar; 31(1):27-30. PubMed ID: 23151355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carnitine for fatigue in multiple sclerosis.
    Tejani AM; Wasdell M; Spiwak R; Rowell G; Nathwani S
    Cochrane Database Syst Rev; 2012 May; 2012(5):CD007280. PubMed ID: 22592719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amantadine and Modafinil as Neurostimulants During Post-stroke Care: A Systematic Review.
    Gagnon DJ; Leclerc AM; Riker RR; Brown CS; May T; Nocella K; Cote J; Eldridge A; Seder DB
    Neurocrit Care; 2020 Aug; 33(1):283-297. PubMed ID: 32394130
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized, double-blind, placebo-controlled trial of psychostimulants for the treatment of fatigue in ambulatory patients with human immunodeficiency virus disease.
    Breitbart W; Rosenfeld B; Kaim M; Funesti-Esch J
    Arch Intern Med; 2001 Feb; 161(3):411-20. PubMed ID: 11176767
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatigue in MS.
    Dulli D; Schutta H
    Neurology; 1996 Nov; 47(5):1351. PubMed ID: 8909465
    [No Abstract]   [Full Text] [Related]  

  • 26. Does amantadine have favourable effects on fatigue in Persian patients suffering from multiple sclerosis?
    Ashtari F; Fatehi F; Shaygannejad V; Chitsaz A
    Neurol Neurochir Pol; 2009; 43(5):428-32. PubMed ID: 20054744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple sclerosis-related fatigue.
    MacAllister WS; Krupp LB
    Phys Med Rehabil Clin N Am; 2005 May; 16(2):483-502. PubMed ID: 15893683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fatigue in multiple sclerosis: a rational approach to evaluation and treatment.
    Rosenberg JH; Shafor R
    Curr Neurol Neurosci Rep; 2005 Mar; 5(2):140-6. PubMed ID: 15743552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A scoping review of rehabilitation interventions that reduce fatigue among adults with multiple sclerosis.
    Asano M; Berg E; Johnson K; Turpin M; Finlayson ML
    Disabil Rehabil; 2015; 37(9):729-38. PubMed ID: 25066069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fatigue in multiple sclerosis - a brief review.
    Induruwa I; Constantinescu CS; Gran B
    J Neurol Sci; 2012 Dec; 323(1-2):9-15. PubMed ID: 22935407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pathophysiology and treatment of fatigue in multiple sclerosis].
    Boërio D; Lefaucheur JP; Hogrel JY; Créange A
    Rev Neurol (Paris); 2006 Mar; 162(3):311-20. PubMed ID: 16585886
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of amantadine for the treatment of fatigue in multiple sclerosis: a systematic review and meta-analysis.
    Perez DQ; Espiritu AI; Jamora RDG
    Neurodegener Dis Manag; 2020 Dec; 10(6):383-395. PubMed ID: 33012266
    [No Abstract]   [Full Text] [Related]  

  • 34. Amantadine and/or transcranial magnetic stimulation for fatigue associated with multiple sclerosis (FETEM): study protocol for a phase 3 randomised, double-blind, cross-over, controlled clinical trial.
    Matias-Guiu JA; González-Rosa J; Hernández MÁ; Martínez-Ginés ML; Portolés A; Pérez-Macías N; Benito-León J; Padrón I; Prieto J; Matias-Guiu J
    BMJ Open; 2024 Jan; 14(1):e078661. PubMed ID: 38176857
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical trial with amantadine and pemoline in elderly patients.
    Montanari C; Vallecorsi GF; Bavazzano A; D'Ayalavalva G; Sanesi P
    Age Ageing; 1976 Feb; 5(1):6-11. PubMed ID: 769506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amantadine therapy for fatigue in multiple sclerosis.
    Murray TJ
    Can J Neurol Sci; 1985 Aug; 12(3):251-4. PubMed ID: 3902184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A randomized controlled trial of amantadine in fatigue associated with multiple sclerosis. The Canadian MS Research Group.
    Can J Neurol Sci; 1987 Aug; 14(3):273-8. PubMed ID: 2889518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of acupuncture for fatigue in patients with relapsing-remitting multiple sclerosis: a randomized controlled trial.
    Khodaie F; Naser Moghadasi A; Kazemi AH; Zhao B
    Acupunct Med; 2023 Aug; 41(4):199-205. PubMed ID: 36722418
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A systematic review of complementary and alternative medicine interventions for the management of cancer-related fatigue.
    Finnegan-John J; Molassiotis A; Richardson A; Ream E
    Integr Cancer Ther; 2013 Jul; 12(4):276-90. PubMed ID: 23632236
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.